Mirae Asset Global ETFs Holdings
NMRA icon

Mirae Asset Global ETFs Holdings’s Neumora Therapeutics NMRA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-50,007
Closed -$50K – 3161
2025
Q1 		$50K Buy
50,007
+2,137
+4% +$3.66K ﹤0.01% 2848
2024
Q4 		$507K Buy
47,870
+1,667
+4% +$20K ﹤0.01% 1910
2024
Q3 		$610K Buy
46,203
+38,068
+468% +$444K ﹤0.01% 1817
2024
Q2 		$80K Buy
+8,135
New +$84.2K ﹤0.01% 2652

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NMRA Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Neumora Therapeutics (NMRA) in Q2 2025, closing a stake of 50,007 shares — an estimated $50K sold.

Mirae Asset Global ETFs Holdings first reported a position in NMRA in Q2 2024 and held it in 4 quarters. The position peaked at $610K in Q3 2024. 98 funds tracked by Wall St. Rank hold NMRA as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Neumora Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 50,007 Neumora Therapeutics shares in Q2 2025, an estimated $50K.
  • Mirae Asset Global ETFs Holdings first reported a position in Neumora Therapeutics in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Neumora Therapeutics position peaked at $610K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.